Published in J Am Coll Cardiol on June 15, 2006
Prehypertension: epidemiology, consequences and treatment. Nat Rev Nephrol (2009) 1.28
Cytomegalovirus infection causes an increase of arterial blood pressure. PLoS Pathog (2009) 1.25
A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile. Int J Clin Pract (2008) 1.16
Optimal blood pressure levels in patients with coronary artery disease. J Am Coll Cardiol (2006) 1.08
Yoga lifestyle intervention reduces blood pressure in HIV-infected adults with cardiovascular disease risk factors. HIV Med (2010) 1.08
Risk factor reduction in progression of angiographic coronary artery disease. Arch Med Sci (2012) 1.08
Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use. J Clin Sleep Med (2014) 1.00
Prehypertension and the risk of coronary heart disease in Asian and Western populations: a meta-analysis. J Am Heart Assoc (2015) 0.93
Clinical effects of hypertension on the mortality of patients with acute myocardial infarction. J Korean Med Sci (2009) 0.87
Five-year follow-up of angiographic disease progression after medicine, angioplasty, or surgery. J Cardiothorac Surg (2010) 0.83
Absence of left ventricular concentric hypertrophy: a prerequisite for zero coronary calcium score. Heart Vessels (2010) 0.82
Is 2015 the primetime year for prehypertension? Prehypertension: a cardiovascular risk factor or simply a risk marker? J Am Heart Assoc (2015) 0.82
Grade-response relationship between blood pressure and severity of coronary atherosclerosis in asymptomatic adults: assessment with coronary CT angiography. Int J Cardiovasc Imaging (2014) 0.80
Impact of high-normal blood pressure measured in emergency room on adverse cardiac events in acute myocardial infarction. Korean Circ J (2012) 0.79
Intravascular ultrasound and optical coherence tomography imaging of coronary atherosclerosis. Int J Cardiovasc Imaging (2015) 0.79
Progression of renal dysfunction in patients with cardiovascular disease. Curr Cardiol Rev (2008) 0.78
Current and Future Treatment of Hypertension in the SPRINT Era. Methodist Debakey Cardiovasc J (2016) 0.77
Characteristics of coronary arterial lesions in patients with coronary heart disease and hypertension. Springerplus (2016) 0.75
In vitro simulation research on the hoop stress of myocardial bridge--coronary artery. J Cardiothorac Surg (2015) 0.75
Are current guidelines optimal for treatment of blood pressure in patients with coronary artery disease? Curr Hypertens Rep (2007) 0.75
Blood pressure levels on progression of coronary atherosclerosis. J Am Coll Cardiol (2007) 0.75
The Prevalence of Risk Factors of Coronary Artery Disease in the Patients who Underwent Coronary Artery Bypass Graft, Shiraz, Iran: Suggesting a Model. Int Cardiovasc Res J (2014) 0.75
Therapeutic modulation of the natural history of coronary atherosclerosis: lessons learned from serial imaging studies. Cardiovasc Diagn Ther (2016) 0.75
The effect of resistance exercise on fitness, blood pressure, and blood lipid of hypertensive middle-aged men. J Exerc Rehabil (2017) 0.75
The management of severe hypertension in Australian general practice. BMC Health Serv Res (2013) 0.75
Imaging of coronary atherosclerosis in various susceptible groups. Cardiovasc Diagn Ther (2016) 0.75
Treating high blood pressure in patients with stable coronary artery disease: how low should we go? Curr Cardiol Rep (2007) 0.75
Hypertension and coronary artery disease: epidemiology, physiology, effects of treatment, and recommendations : A joint scientific statement from the Austrian Society of Cardiology and the Austrian Society of Hypertension. Wien Klin Wochenschr (2016) 0.75
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med (2010) 22.04
Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med (2011) 15.70
Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med (2012) 13.59
Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. N Engl J Med (2014) 10.66
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA (2003) 10.55
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA (2004) 9.91
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA (2006) 9.27
Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med (2013) 8.74
Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest. JAMA (2009) 8.56
Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med (2012) 7.93
Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. PLoS Med (2009) 6.89
Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med (2007) 6.79
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet (2010) 6.23
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA (2007) 5.89
Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med (2003) 5.89
Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med (2005) 4.64
Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med (2003) 4.61
Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation (2002) 4.31
Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med (2007) 4.30
Medical device recalls and the FDA approval process. Arch Intern Med (2011) 4.01
Effect of ACAT inhibition on the progression of coronary atherosclerosis. N Engl J Med (2006) 3.90
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA (2008) 3.64
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med (2003) 3.61
Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med (2011) 3.52
Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol (2004) 3.50
Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA (2007) 3.25
Outcomes following transcatheter aortic valve replacement in the United States. JAMA (2013) 2.88
Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden. Circulation (2008) 2.34
High-dose statins in acute coronary syndromes: not just lipid levels. JAMA (2004) 2.31
Left main trunk coronary artery dissection as a consequence of inaccurate coronary computed tomographic angiography. Arch Intern Med (2010) 2.21
Percutaneous coronary intervention in patients with severe aortic stenosis: implications for transcatheter aortic valve replacement. Circulation (2012) 2.17
A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial. Circ Heart Fail (2011) 2.15
Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. J Am Coll Cardiol (2008) 2.08
Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. J Am Coll Cardiol (2010) 2.05
Enhanced prediction of mortality after percutaneous coronary intervention by consideration of general and neurological indicators. JACC Cardiovasc Interv (2011) 2.01
The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis. Arch Intern Med (2010) 1.98
Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound. J Am Coll Cardiol (2006) 1.87
Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction. Circulation (2007) 1.85
Coronary artery calcification and changes in atheroma burden in response to established medical therapies. J Am Coll Cardiol (2006) 1.84
The rise and fall of rosiglitazone. Eur Heart J (2010) 1.76
Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease. Clin Chem (2010) 1.74
Comparison of stent versus balloon angioplasty for pulmonary vein stenosis complicating pulmonary vein isolation. J Cardiovasc Electrophysiol (2008) 1.71
Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial. J Am Coll Cardiol (2011) 1.71
Successful percutaneous management of left main trunk occlusion during percutaneous aortic valve replacement. Catheter Cardiovasc Interv (2009) 1.69
Multidetector computed tomographic angiography in planning of reoperative cardiothoracic surgery. Ann Thorac Surg (2008) 1.69
Potential of dual-energy computed tomography to characterize atherosclerotic plaque: ex vivo assessment of human coronary arteries in comparison to histology. J Cardiovasc Comput Tomogr (2008) 1.66
Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism. JACC Cardiovasc Interv (2012) 1.65
SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr (2012) 1.65
Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN. Eur Heart J Cardiovasc Imaging (2014) 1.64
CT imaging for acute aortic syndrome. Cleve Clin J Med (2008) 1.62
Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial. Am Heart J (2013) 1.62
Temporal trends in utilization of cardiac computed tomography. J Cardiovasc Comput Tomogr (2008) 1.61
Interventional cardiology perspective of functional tricuspid regurgitation. Circ Cardiovasc Interv (2009) 1.61
Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol (2005) 1.59
Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis. J Am Coll Cardiol (2009) 1.58
Valsalva sinus aneurysms: findings at CT and MR imaging. Radiographics (2010) 1.57
Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement. J Thorac Cardiovasc Surg (2009) 1.57
Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol. J Am Coll Cardiol (2010) 1.56